Biomarin Pharmaceutical Stock Forecast

Buy or Hold candidate since Jun 26, 2026 Gain 2.15%

The BioMarin Pharmaceutical Inc. stock price gained 1.58% on the last trading day (Monday, 27th Jul 2026), rising from $59.33 to $60.27. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.69% from a day low at $59.38 to a day high of $60.98. The price has risen in 6 of the last 10 days and is up by 1.81% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 78 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $87.12 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.66% during the next 3 months and, with a 90% probability hold a price between $63.97 and $71.29 at the end of this 3-month period.

BMRN Signals & Forecast

The BioMarin Pharmaceutical Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $59.25 and $57.91. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -0.133%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The stock had a Golden Star Signal on Monday, August 25, 2025 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for BioMarin Pharmaceutical Inc. stock

BioMarin Pharmaceutical Inc. finds support from accumulated volume at $57.29 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $1.60 between high and low, or 2.69%. For the last week the stock has had daily average volatility of 2.44%.

Our recommended stop-loss: $57.84 (-4.04%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 14 days ago.)

Trading Expectations (BMRN) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect BioMarin Pharmaceutical Inc. to open at $60.21, and during the day (based on 14 day Average True Range), to move between $59.52 and $61.02, which gives a possible trading interval of +/-$1.50 (+/-2.52%) up or down from last closing price. If BioMarin Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 2.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $60.35 (0.13%) than the support at $57.29 (4.94%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioMarin Pharmaceutical Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BioMarin Pharmaceutical Inc. stock to perform well in the short-term.

Current score: 4.229 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 28, 2026 - $60.21 ( 0.0996%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk